Insuline icodec injectable à administration hebdomadaire pour les adultes vivant avec le diabète
Authors:
Open Access
- 24 March 2025
- journal article
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 197 (11) , E303-E304
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trialsDiabetes, Obesity and Metabolism, 2024
- Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trialThe Lancet, 2023
- Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous InsulinNew England Journal of Medicine, 2023
- Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 DiabetesJAMA, 2023
- HypoglycemiaCanadian Journal of Diabetes, 2018